Evidence map›Paper›PMID 28143876›Full record

SynthesisEuropean respiratory review : an official journal of the European Respiratory Society2017

C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis.

Giovanni Leuzzi, Carlotta Galeone, Francesca Taverna, Paola Suatoni, Daniele Morelli, Ugo Pastorino

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in European respiratory review : an official journal of the European Respiratory Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.International journal of chronic obstructive pulmonary disease
    Pooled it
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Giovanni LeuzziThoracic Surgery Unit, IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy giovanni.leuzzi@istitutotumori.mi.it.
Carlotta GaleoneDept of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Francesca TavernaImmunohematology and Transfusion Medicine Service, IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy.
Paola SuatoniThoracic Surgery Unit, IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy.
Daniele MorelliDept of Pathology and Laboratory Medicine, IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy.
Ugo PastorinoThoracic Surgery Unit, IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognostic role of baseline C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) is controversial. In order to clarify this issue, we performed a systematic review and meta-analysis to assess the predictive effect of baseline CRP level in COPD patients. 15 eligible articles focusing on late mortality in COPD were included in our study. We performed a random-effects meta-analysis, and assessed heterogeneity and publication bias. We pooled hazard ratio (HR) estimates and their 95% confidence intervals on mortality for the comparison between the study-specific highest category of CRP level versus the lowest category. In overall analysis, elevated baseline CRP levels were significantly associated with higher mortality (HR 1.53, 95% CI 1.32-1.77, I

Indexed as

Asian PeopleBiomarkersC-Reactive ProteinHumansMultivariate AnalysisOdds RatioPredictive Value of TestsPrognosisPulmonary Disease, Chronic ObstructiveRisk AssessmentRisk FactorsTime FactorsUp-RegulationBiomarkersC-Reactive Protein

Identifiers

PMID28143876
PMCPMC9488765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.